Related Experiment Video

Updated: Aug 9, 2026

Measurement of Antibody Effects on Cellular Function of Isolated Cardiomyocytes
13:42

Measurement of Antibody Effects on Cellular Function of Isolated Cardiomyocytes

Published on: March 8, 2013

[Humoral immunity and lymphocyte subsets in patients with dilated cardiomyopathy]

M Maruta1, K Takenaka, H Takabe

  • 1Department of Central Clinical Laboratory, Kinki University Hospital, Osaka-sayama.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|August 1, 1991
PubMed

Insights

Dilated cardiomyopathy (DCM) patients show immune system abnormalities, particularly a higher CD4/CD8 ratio and fewer CD8 cells. These changes correlate with disease severity and suggest immune status aids in predicting DCM progression and treatment.

Area of Science:

  • Immunology
  • Cardiology
  • Pathophysiology

Context:

  • Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
  • Understanding the interplay between cardiac damage and immune response is crucial for effective management.
  • Previous studies have hinted at immune system involvement in DCM, but specific immunological markers require further elucidation.

Purpose:

  • To investigate specific immunological abnormalities in patients diagnosed with dilated cardiomyopathy.
  • To correlate these immunological findings with the clinical severity of DCM, including NYHA classification and cardiac imaging.
  • To explore the potential of immunological assessment in predicting disease progression and guiding therapeutic strategies for DCM.

Summary:

  • Patients with dilated cardiomyopathy (DCM) exhibited distinct immunological alterations, including an elevated CD4/CD8 ratio and a reduced count of CD8 cells within lymphocyte subsets.
  • These immune system dysregulations were more pronounced in individuals with a history of myocarditis.
  • Advanced DCM severity (NYHA IV class) was associated with increased cardiothoracic ratio (CTR), enlarged left ventricular dimensions, and diminished ejection fraction, suggesting a link between myocardial damage duration and immune abnormalities.

Impact:

  • The study highlights that persistent myocardial damage in DCM can lead to lasting immunological abnormalities.
  • Assessing the immunological status of DCM patients offers valuable insights for anticipating disease trajectory.
  • These findings support the utility of immunological profiling in tailoring medical treatment plans for individuals with dilated cardiomyopathy.

More Related Videos

Isolation and Identification of Extravascular Immune Cells of the Heart08:24

Isolation and Identification of Extravascular Immune Cells of the Heart

Published on: August 23, 2018

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...